Subscribe to RSS
DOI: 10.1055/s-0043-1769505
Ketogenic Diet in Neonates with Drug-Resistant Epilepsy: Efficacy and Side Effects—A Single Center's Initial Experience
Funding None.![](https://www.thieme-connect.de/media/neuropediatrics/202305/lookinside/thumbnails/10-1055-s-0043-1769505_0120233392oa-1.jpg)
Abstract
Background For patients with pharmacoresistant epilepsy, a therapeutic option is ketogenic diet. Currently, data on young infants are scarce, particularly during hospitalization in the neonatal intensive care unit (NICU).
Objective The aim of the present study was to evaluate the short-term (3-month) efficacy and side effects of ketogenic diet in infants with “drugs-resistant” epilepsy treated during NICU stay.
Methods This retrospective study included infants aged under 2 months started on ketogenic diet during NICU hospitalization to treat drug-resistant epilepsy from April 2018 to November 2022.
Results Thirteen term-born infants were included, three (23.1%) of whom were excluded because they did not respond to the ketogenic diet. Finally, we included 10 infants. Six (60%) patients took three antiepileptics before starting the ketogenic diet, while four (40%) took more drugs. Diet had a good response in four (40%) patients. In four patients, the ketogenic diet was suspended because of the onset of serious side effects. The emetic levels of sodium, potassium, and chlorine, pH, and onset of diarrhea, constipation, and gastroesophageal reflux showed significant differences. Ketonuria was higher and blood pH lower in the group that took more than three drugs than in the group taking fewer than three drugs.
Conclusion The ketogenic diet is efficacious and safe in infants, but the early and aggressive management of adverse reactions is important to improve the safety and effectiveness of the ketogenic treatment.
Authors' Contributions
R.F. and M.R. conceived and designed the study. V.S., A.D.C., A.P., and L.M. acquired the data. G.F.P. performed the statistical analysis. All authors have interpreted the data and approved the submitted version.
Publication History
Received: 15 January 2023
Accepted: 18 April 2023
Article published online:
15 June 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Eltze CM, Chong WK, Cox T. et al. A population-based study of newly diagnosed epilepsy in infants. Epilepsia 2013; 54 (03) 437-445
- 2 Aaberg KM, Gunnes N, Bakken IJ. et al. Incidence and prevalence of childhood epilepsy: a nationwide cohort study. Pediatrics 2017; 139 (05) e20163908
- 3 Kwan P, Arzimanoglou A, Berg AT. et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51 (06) 1069-1077
- 4 Ramos-Lizana J, Rodriguez-Lucenilla MI, Aguilera-López P, Aguirre-Rodríguez J, Cassinello-García E. A study of drug-resistant childhood epilepsy testing the new ILAE criteria. Seizure 2012; 21 (04) 266-272
- 5 Epilepsies in children, young people and adults NICE guideline Published: 27 April 2022. Accessed April 27, 2023, at: www.nice.org.uk/guidance/ng217
- 6 Moon KimJ. Ketogenic diet: Old treatment, new beginning. Editorial Clinical Neurophysiology Practice 2 (2017) 161–162. DOI: 10.1016/j.cnp.2017.07.001.
- 7 Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev 2020; 6 (06) CD001903
- 8 Nordli Jr DR, Kuroda MM, Carroll J. et al. Experience with the ketogenic diet in infants. Pediatrics 2001; 108 (01) 129-133
- 9 Kossoff EH, Pyzik PL, McGrogan JR, Vining EPG, Freeman JM. Efficacy of the ketogenic diet for infantile spasms. Pediatrics 2002; 109 (05) 780-783
- 10 Hong AM, Turner Z, Hamdy RF, Kossoff EH. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia 2010; 51 (08) 1403-1407
- 11 Wirrell E, Eckert S, Wong-Kisiel L, Payne E, Nickels K. Ketogenic diet therapy in infants: efficacy and tolerability. Pediatr Neurol 2018; 82: 13-18
- 12 Lyons L, Schoeler NE, Langan D, Cross JH. Use of ketogenic diet therapy in infants with epilepsy: a systematic review and meta-analysis. Epilepsia 2020; 61 (06) 1261-1281
- 13 Cobo NH, Sankar R, Murata KK, Sewak SL, Kezele MA, Matsumoto JH. The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: challenges in implementation in the pediatric and neonatal intensive care units. Child Neurol 2015; 30 (02) 259-266
- 14 Thompson L, Fecske E, Salim M, Hall A. Use of the ketogenic diet in the neonatal intensive care unit-Safety and tolerability. Epilepsia 2017; 58 (02) e36-e39
- 15 Kuhn M. Building predictive models in R using the caret package. J Stat Softw 2008; 28 (05) 1-26
- 16 Wei T, Simko V. R package 'corrplot': Visualization of a Correlation Matrix. (Version 0.92), 2021. Accessed April 27, 2023, at: https://github.com/taiyun/corrplot
- 17 Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952; 47: 583-621
- 18 Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965; 52 (3–4): 591-611
- 19 Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945; 1: 80-83
- 20 Ronen GM, Penney S, Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr 1999; 134 (01) 71-75
- 21 Glass HC, Shellhaas RA, Wusthoff CJ. et al; Neonatal Seizure Registry Study Group. Contemporary profile of seizures in neonates: a prospective cohort study. J Pediatr 2016; 174: 98-103.e1
- 22 Nolan MA, Redoblado MA, Lah S. et al. Intelligence in childhood epilepsy syndromes. Epilepsy Res 2003; 53 (1-2): 139-150
- 23 Falsaperla R, D'Angelo G, Praticò AD. et al. Ketogenic diet for infants with epilepsy: a literature review. Epilepsy Behav 2020; 112: 107361
- 24 Perucca E. Pharmacokinetic interactions with antiepileptic drugs. Clin Pharmacokinet 1982; 7 (01) 57-84
- 25 Chentouf A. Ketogenic diet: a therapeutic alternative in pediatric refractory epilepsies.) Nor. Afr J Food Nutr Res 2022; 6 (13) 39-45
- 26 Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007; 48 (01) 43-58
- 27 Barzegar M, Afghan M, Tarmahi V, Behtari M, Rahimi Khamaneh S, Raeisi S. Ketogenic diet: overview, types, and possible anti-seizure mechanisms. Nutr Neurosci 2021; 24 (04) 307-316
- 28 Simeone TA, Simeone KA, Rho JM. Ketone bodies as anti-seizure agents. Neurochem Res 2017; 42 (07) 2011-2018
- 29 Lutas A, Yellen G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci 2013; 36 (01) 32-40
- 30 Youngson NA, Morris MJ, Ballard JWO. The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metabolism-altering drugs. Seizure 2017; 52: 15-19
- 31 Wells J, Swaminathan A, Paseka J, Hanson C. Efficacy and safety of a ketogenic diet in children and adolescents with refractory epilepsy-a review. Nutrients 2020; 12 (06) 1809
- 32 Best TH, Franz DN, Gilbert DL, Nelson DP, Epstein MR. Cardiac complications in pediatric patients on the ketogenic diet. Neurology 2000; 54 (12) 2328-2330
- 33 Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 2007; 22 (04) 375-378
- 34 Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004; 45 (09) 1116-1123
- 35 Cai QY, Zhou ZJ, Luo R. et al. Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr 2017; 13 (06) 528-536